Disrupted circadian rhythms may influence tumor immunity and cancer spread
Epidemiological studies link light at night (LAN), shift work, chronic jet lag (CJL), and core clock gene mutations…
Simple urine test can accurately diagnose and track bladder cancer
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System…
Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…
Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage…
MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or…
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to…
New integrated framework advances precision surgery for liver cancer
Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. Despite…
Tumor environments sculpt diverse natural killer cells for cancer therapies
For decades, natural killer (NK) cells have been classified into two main groups based on surface markers: one…
Immunotherapy shows potential for treating rising gynecological tumors
Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health…
Kids News: Melanoma vaccine and human brain cells powering AI just two big breakthroughs this National Science Week
Skin cancer prevention and a new “human” AI – there certainly have been some exciting new developments to…
Skin cancer vaccine breakthrough by Moderna and Merck
Pharmaceutical giant Moderna’s share price exploded by more than 170 per cent overnight as investors reacted to its…
MEK inhibition could limit T cell exhaustion and give a boost to immunotherapy
A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to…